ARVN - Arvinas Charts, Trade Ideas, Earnings, Ratings

TRENDING : Top 50 XLF (-0.8%) F (-0.89%) BTCUSD (%) AAPL (0.17%) APPS (-4.27%) EXPI (7.9%) FCEL (19.89%) FUTU (0.92%) IRBT (9.15%) MGNI (0.19%) NDAQ (-0.83%) PLUG (11.36%) REGI (-2%) SPWR (13.93%) XSPA (-1.54%) EVGN (6.07%) ETHUSD (%) ENDP (0.55%) ELY (-0.11%) DQ (5.99%) DGLY (8.27%) DAR (-0.97%) CVET (-4.42%) COWN (-1.95%) CLNE (-1.2%)

Recommendation

Service : Tech Trades | Trader : Tech Trades | Trade Date : 12/15/20

$ARVN - Arvinas

Buy Long

Trade

4.88 %

Target

$71.51

Issue Price

$75.00

Target Price

12/30/20

Target Date

$36.00

Stop Loss

Trade Closed

Hit Target Price

Reason

-6.01 %

P/L %

$67.21

Close Price

0

Days Held

12/16/20

Closed Date

To view trade details and get more recommendations from this trader Follow

Down 10% to $73.55 today

ARVN - Arvinas

$74.03 -8.48[-10.28%]

15 mins delayed data

People also watch :

+Watchlist

2 StockHoot Traders following this.
Analyst Ratings | Earnings

Previous Close	$82.51	Open	$81.45
Volume	594.1K	Market Cap	3.995B
Yield		Last Dividend

Day

52 Week

The Daily Biotech Pulse: FDA Nod For Amp...	12/29/20
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Dec. 28) Acl...

ARVN Climbs on Stock Offering	12/15/20
Arvinas Inc (NASDAQ:ARVN) reported a proposed offering of $250 million of common stock. The New Haven, Conn.-based company, a clinical-stage biotechno...

ROCE Insights For Arvinas	12/15/20
In Q3, Arvinas (NASDAQ: ARVN) posted sales of $7.60 million. Earnings were up 19.88%, but Arvinas still reported an overall loss of $31.75 million. In...

Alexion, Calyxt, Arvinas: 5 Top Stock Ga...	12/14/20
Alexion Pharmaceuticals, Calyxt, Homology Medicines, Arvinas and SandRidge Energy are five top stock gainers for Monday.

Stocks making the biggest moves midday: ...	12/14/20
DoorDash and Airbnb get downgraded. Elliott Management takes a stake in Public Storage.

Arvinas eyes a busy 2021 as protein degr...	12/14/20
Just in time for the holiday season, Arvinas??? lead protein degraders delivered promising early results in patients with hard-to-treat breast or pros...

Arvinas News Alert: Why ARVN Stock Is Sk...	12/14/20
Arvinas (ARVN) news for Monday includes positive interim results from clinical trials sending ARVN stock soaring to new highs.

Return On Capital Employed Overview: Arv...	12/14/20
During Q3, Arvinas's (NASDAQ: ARVN) reported sales totaled $7.60 million. Despite a 19.88% in earnings, the company posted a loss of $31.75 million. I...

Arvinas (NASDAQ:ARVN) Stock Rating Lower...	10/22/20
Arvinas (NASDAQ:ARVN) was downgraded by equities researchers at BidaskClub from a ???sell??? rating to a ???strong sell??? rating in a research note i...

Arvinas Appoints Linda Bain to its Board...	06/11/20
NEW HAVEN, Conn., June 11, 2020 -- Arvinas, Inc. , a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degr...

Arvinas, Inc. (ARVN) Upgraded to Buy: He...	06/05/20
Arvinas, Inc. (ARVN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive ...

The Daily Biotech Pulse: Gilead Signs Ma...	05/13/20
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 12) Acce...

How Arvinas (ARVN) Stock Stands Out in a...	05/12/20
Arvinas (ARVN) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

Arvinas, Inc. (ARVN) Upgraded to Buy: He...	05/05/20
Arvinas, Inc. (ARVN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive ...

The Daily Biotech Pulse: FDA Nod For Gla...	04/30/20
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 29) ??...

Arvinas Reports Q4 and Full Year 2019 Fi...	03/16/20
Arvinas reported financial results for the fourth quarter and full year ended December 31, 2019 and provided a corporate update. The post Arvinas Repo...

The Daily Biotech Pulse: Assertio To Sel...	02/07/20
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 6) A...

The Daily Biotech Pulse: Novo Nordisk's ...	01/17/20
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs o...

The Daily Biotech Pulse: Nektar Withdraw...	01/15/20
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs o...

The Daily Biotech Pulse: European Nod Fo...	12/12/19
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Dec. 11) ...

The Daily Biotech Pulse: Correvio Faces ...	12/11/19
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Dec. 10) ...

The Daily Biotech Pulse: ASH Meeting Wra...	12/10/19
The following are top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs Dec. 9.) Acce...

The Daily Biotech Pulse: ChemoCentryx Tr...	11/26/19
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs on Nov. 25....

Arvinas TPD Therapies Have Great Potenti...	11/25/19
Arvinas Inc (NASDAQ: ARVN ) shares have been on a tear ever since the company issued a platform update in late October. The Analyst Guggenheim Securit...

The Daily Biotech Pulse: Roche-Spark Dea...	11/22/19
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs on Nov. 21....

The Daily Biotech Pulse: Endo's Cellulit...	11/20/19
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Nov. 19) ...

The Daily Biotech Pulse: Therapix To Rev...	11/19/19
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Nov. 18) ...

Hedge Funds Are Selling Arvinas, Inc. (A...	10/30/19
Is Arvinas, Inc. (NASDAQ:ARVN) a good investment right now? We check hedge fund and billionaire investor sentiment before delving into hours of resear...

Arvinas EPS in-line, beats on revenue	05/08/19
No summary available.

Arvinas: Early-Stage Research In An Exci...	04/01/19
No summary available.

ANALYST RATINGS

0 analyst ratings (Last 3 months)

0.00 %

Strong Buy + Buy

Price Target (PT)

EARNINGS

Date	2020-11-05 (BMO)	Est. (EPS/Rev.)	($0.68)/ 5.22M
Actual (EPS/Rev.)	$-0.79/ $7.60 M	EPS (TTM)	0

TRADERS TRACKING $ARVN

Service Name	Trader	% Success
Tech Trades	Tech Trades	81.00 %	Follow
Follow The Insiders	Akemi Mokoto	54.00 %	Follow

SHOW ALL TRADERS

About Us

Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.

Product Types

Strategies

Follow Us

Secure Payments

We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.